Any CoC, NAPBC, or NAPRC-accredited program that is interested in participating in this project is encouraged to do so. The “Intent to participate survey” can be found on the project website and is due by January 31, 2027. Completion of the survey link ensures your participation.
At least one member from each team is required to attend or listen to the recording after the call. While it is not a requirement that all QI team members attend every call, it is encouraged.
Yes, programs can participate with on-site or off-site testing processes.
Yes, we encourage programs to participate regardless of having a geneticist/genetic counselor on staff.
You must submit all patients, within the specified time frame (or 20% of the population you serve if over 20 patients per time period), that receive a diagnosis. Submission should include the first 20 sequential patients.
Yes, we encourage patients to participate even if they see less than 20 eligible patients in a data submission period. We would encourage programs to submit all eligible patients diagnosed within the data submission period.
Yes, a NAPRC program can choose to submit only rectal cancer patients if they have a large enough caseload to submit 20 rectal patients in a data collection cycle. For NAPRC programs with a smaller caseload, it is recommended to include colon patients to have a larger population.
You do not need to abstract data concurrently, but you will need to conduct a retrospective chart review or pull data via a specific report to ensure inclusion of patients. Non-PHI will be entered into REDCap via a web link sent to the primary contact.
REDCap is a data collection tool that can be accessed online to complete your data. REDCap will be used for all GeneQIP submissions. Programs do not need personal Redcap accounts. Programs will receive surveys to enter and submit all data.
No. The software is accessed through a link on the project web page and completed online. This secure database is unique to the American College of Surgeons and does not require any downloads or IT interface with your systems. You will not need IT permissions or admin rights to access the program.
No, though it is strongly encouraged that the team discuss the qualitative points in the questionnaire prior to completing. A primary contact is required, and the email associated with this primary contact will be the one used to communicate about the project and access subsequent questionnaires. If this individual leaves or needs to be changed, you will need to contact cancerqi@facs.org to change the primary contact in the REDCap for your program.
No. Patients will not sign a participation agreement or consent. We are not gathering any patient-identifying data.
Please contact cancerQI@facs.org and specify which form you need to update. You will be provided with a survey link and an access code to make the necessary changes.
Each form is assigned a unique access code. If you need to update multiple forms, a separate code will be provided for each.
This data may be captured through template documentation in the record, and a review of chart data will most likely need to be done. Consider your current workflows and resources, and what is most feasible for your program.
Yes, we encourage participation by programs working toward their first accreditation as long as the application for accreditation has been submitted and a company identification number has been issued. This Company Identification Number is a required field in the initial Intent to Participate.
Yes, participation in this project and completing requirements may be counted toward a deficiency resolution for designated standards. It may not be applied to an unrelated standard.
No. You simply need to upload the attestation form at the end of the calendar year. This form is sent out by cancerqi@facs.org following receipt of all data cycles. It is strongly encouraged you also save copies of the data you submitted and any other QI worksheets, RCA documents, or correspondence from the project. These will need to be uploaded to demonstrate your 2026 compliance in your Pre-Review Questionnaire (PRQ) during the year of your next site visit. Although sites do not need to complete the template, they may find it beneficial for summarizing the project and tracking the updates to the cancer committee.
For network (INCP/NCIN) programs, is this project done at the network parent level? Or must it be done at each of the children?
For Network Accreditations (INCP/NCIN) this project is done at the child level only. A second QI project including all sites would need to be done.
You do not need to let the CoC/NAPBC/NAPRC know ahead of time if you are participating in this QI project. Documentation indicating your participation will be given to you at the end of each calendar year, and you will upload a letter certifying your full participation. You will still need to provide status updates and document in the meeting minutes your progress to the cancer committee or breast/rectal program leadership committee. It is encouraged that you complete the relevant reporting template but is not required.
Yes, the program must do a breast and colorectal project. GeneQIP will count toward each year for CoC and one accreditation cycle for NAPBC and NAPRC.
Yes, the program will receive credit for one NAPBC cycle. The program should only submit breast patients.
Yes, the program will receive credit for one NAPRC cycle. The program should only submit colorectal patients.
Yes, the program will be required to complete both a breast and rectal project. The program should submit two separate Intent to Participate forms to ensure proper documentation.
Yes, the program will receive credit for both 2027 & 2028 if they satisfy all requirements. Programs can choose to complete a breast or colorectal cancer project.